Chiron Real Estate (XRN) Q1 2025 earnings summary

Executive summary

• Portfolio occupancy was 95.6% with a weighted average lease term of 5.6 years and rent coverage ratio of 4.4x as of Q1 2025.

• Net income attributable to common shareholders rose to $2.1 million ($0.03/share), up from $0.8 million ($0.01/share) year-over-year, driven by gains on property sales and lower G&A expenses.

• Completed $69.6 million acquisition of a five-property medical portfolio, adding 486,598 leasable square feet and $6.3 million in annualized base rent; three properties closed in Q1, two in April 2025.

• CEO succession plan is underway, with a new CEO expected by June 30, 2025; current CEO will transition to Chairman.

• Prospect Medical Group, a tenant, filed for Chapter 11 in January 2025, impacting lease income and resulting in lease rejections and negotiations.

Financial highlights

• Total revenues for Q1 2025 were $34.6 million, down 1.4% year-over-year, primarily due to property dispositions.

• FFO and AFFO per share/unit were $0.20 and $0.22, both down $0.01 from the prior year quarter.

• General and administrative expenses decreased to $3.6 million from $4.4 million, mainly due to lower non-cash LTIP compensation.

• Two property dispositions generated $8.2 million in gross proceeds and a $1.4 million gain.

• Interest expense increased to $7.2 million from $6.9 million year-over-year due to higher average borrowings.

Outlook and guidance

• Reaffirmed full-year 2025 AFFO per share/unit guidance of $0.89–$0.93, excluding one-time CEO succession expenses.

• Guidance assumes no additional acquisitions/dispositions or equity/debt issuances beyond those already announced.

• Management expects continued acquisition activity, with two additional properties acquired in April 2025 for $38.1 million.